Sandbox Reserved 467: Difference between revisions
| Line 44: | Line 44: | ||
- n-methyl-{4-[2-(7-oxo-6, 7-dihydro-8h-[1,3]thiazolo[5,4-e] indol-8-ylidene) hydrazine]phenyl}methanesulfonamide | - n-methyl-{4-[2-(7-oxo-6, 7-dihydro-8h-[1,3]thiazolo[5,4-e] indol-8-ylidene) hydrazine]phenyl}methanesulfonamide | ||
<ref name="model" /> | <ref name="model" /> | ||
- (2r)-1-(dimethylamino)-3-{4-[6-{[2-fluoro-5-(trifluoromethyl)phenyl] amino}pyrimidin-4-yl)amino]phenoxy}propan-2-ol <ref name="model" /> | - (2r)-1-(dimethylamino)-3-{4-[6-{[2-fluoro-5-(trifluoromethyl)phenyl] amino}pyrimidin-4-yl)amino]phenoxy}propan-2-ol <ref name="model" /> | ||
- (5-chloropyrazolo[1,5-a]pyrimidin-7-yl)-(4-methanesulfonylphenyl)amine | - (5-chloropyrazolo[1,5-a]pyrimidin-7-yl)-(4-methanesulfonylphenyl)amine | ||
<ref name="model" /> | <ref name="model" /> | ||
- din-232306 6-(3,4-dihydroxybenzyl)-3-ethyl-1-(2,4,6-trichlorophenyl-1h-pyrazolo[3,4-d]pyrimidin-4(5h)-one<ref name="model" /> | - din-232306 6-(3,4-dihydroxybenzyl)-3-ethyl-1-(2,4,6-trichlorophenyl-1h-pyrazolo[3,4-d]pyrimidin-4(5h)-one<ref name="model" /> | ||